Intra-nasal infection of macaques with yellow fever (YF) vaccine strain 17D: A novel and economical approach for YF vaccination in man

Vaccine

Volumn 17, Issue 9-10, 1999, Pages 1206-1210

  Niedrig, M ^a   Stolte, N ^b   Fuchs, D ^c   Hunsmann, G ^b   Stahl Hennig, C ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b GERMAN PRIMATE CENTER   (Germany)

^c Inst fuer Med Chemie Biochemie   (Austria)

Author keywords

Intra nasal immunisation; Vaccination; Yellow Fever virus

Indexed keywords

LIVE VACCINE; NEOPTERIN; YELLOW FEVER VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNOFLUORESCENCE TEST; INTRANASAL DRUG ADMINISTRATION; MACACA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHESUS MONKEY; SUBCUTANEOUS DRUG ADMINISTRATION; VIREMIA; VIRUS ATTENUATION; VIRUS NEUTRALIZATION; YELLOW FEVER;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODY FORMATION; FLUORESCENT ANTIBODY TECHNIQUE; MACACA MULATTA; NEOPTERIN; NEUTRALIZATION TESTS; POLYMERASE CHAIN REACTION; VIRAL VACCINES; YELLOW FEVER;

EID: 0033525787     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00344-2     Document Type: Article

References (26)

1. Theiler M., Smith H.H. The use of yellow fever modified by in vitro cultivation for human immunization. J Exp Med. 65:1937;787-800.
2. Monath TP. Yellow fever vaccines: the success of empiricism, pitfalls of application, and transition to molecular vaccinology. In: Plotkin S, Fantini B, editors. Vaccinia, vaccination and vaccinology: Jenner, Pasteur and their successors. Paris: Elsevier, 1996. p. 157-82.
3. Groot H., Ribeiro R.B. Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine. Bull World Health Org. 27:1962;699-707.
4. Robertson S.E., Hull B.P., Tomori O., Bele O., LeDuc J.W., Esteves K. Yellow Fever: a decade of reemergence. JAMA. 276(14):1996;1157-1162.
5. Fu Z.F., Rupprecht C.E., Dietzschold B., Saikumar P., Niu H.S., Babka I., Wunner W.H., Koprowski H. Oral vaccinations of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein. Vaccine. 11(9):1993;925-928.
6. Sabin A.B., Boulger L.R. History of the Sabin attenuated poliovirus oral live vaccine strain. J Biol Stand. 1:1973;115.
7. Johnson P.R., Feldman S., Thompson J.M., Mahoney J.D., Wright P.F. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J Med Virol. 17:1985;325-335.
8. Barry D.W.et al. Requirements for Yellow Fever vaccine. WHO Tech Rep Ser. 594:1976;34-35.
9. De Madrid A.D., Porterfield J.S. A simple micro-culture method for the study of group B arboviruses. Bull World Health Org. 40:1969;113-121.
10. Boom R., Sol C.J., Salimans M.M., Jansen C.L., Wertheim-van Dillen P.M., van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 28:1990;495-503.
11. Eldahah Z.A., Asher D.M., Godec M.S., Pomeroy K.L., Goldfarb L.G., Feinstone S.M., Levitan H., Gibbs C.J., Gajdusek D.C. Detection of flaviviruses by reverse transcriptase polymerase chain reaction. J Med Virol. 33:1991;260-267.
12. Smithburn K.C., Mahaffy A.F. Immunization against yellow fever: studies on time of development and duration of induced immunity. Am J Trop Med. 25:1945;217-223.
13. Hill A.B., Müllbacher A., Parrish C., Coia G., Westaway E.G., van Blanden R. Broad cross-reactivity with marked fine specificity in the cytotoxic T-cell response to flaviviruses. J Gen Virol. 73:1992;1115-1123.
14. Monath TP. Pathobiology of the flaviviruses. In: Schlesinger S, Schlesinger MJ, editors. The Togaviridae and Flaviviridae. New York: Plenum Press, 1986. p. 375-440.
15. Jänisch T., Preiser W., Berger A., Niedrig M., Mikulicz U., Thoma B., Doerr H.W. Emerging viral pathogens in long-term expatriates (II) dengue virus. Trop Med Int Health. 2(10):1997;934-940.
16. Huber C., Batchelor J.R., Fuchs D., Hausen A., Lang A., Niederwieser A., Reibnegger G., Swetly P., Troppmair J., Wachter J. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon gamma. J Exp Med. 160:1984;310-316.
17. Fendrich C., Lüke W., Stahl-Hennig C., Herchenröder O., Fuchs D., Wachter H., Hunsmann G. Urinary neopterin concentrations in rhesus monkeys after infection with simian immunodeficiancy virus strain 251. AIDS. 3:1989;305-307.
18. Rosenzweig E.C., Babione R.W., Wisseman C.L. Jr. Immunological studies with group B arthropod-borne viruses, IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine. Am J Trop Med Hyg. 12:1963;230-235.
19. Poland J.D., Calisher C.H., Monath T.P., Downs W.G., Murphy K. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Org. 59(6):1981;895-900.
20. Fuchs D., Hausen A., Reibnegger G., Werner E.R., Dierich M.P., Wachter H. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol Today. 9:1988;150-155.
21. Reinhardt B, Jaspert R, Niedrig M, Kostner M, L'age-Stehr J. Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. 1998; 56, 159-167.
22. Blancou J., Kieny M.P., Lathe R., Lecocq J.P., Pastoret P.P., Soulebot J.P., Desmettre P. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature. 322:1986;373.
23. Cowdrey S.C. Sensitization to duck-embryo rabies vaccine produced by prior Yellow Fever vaccination. N Engl J Med. 274:1966;1311.
24. Abb J., Deinhardt F., Eisenburg J. The risk of transmission of hepatitis B virus using jet injection in inoculation. J Infect Dis. 144(2):1981;179.
25. Brink P.R.G., van Loon A.M., Trommelen J.C.M., Gribnau F.W.J., Smale-Novakova I.R.O. Virus transmission by subcutaneous jet injection. J Med Microbiol. 20:1985;393-397.
26. Shah R., Mackey K., Wallace H., Yawata K., Roberto R., Meissinger J., Ascher M., Hagens S., Chin J. Hepatitis B associated with jet gun injection: California. Morbid Mortal Wkly Rep. 35(23):1986;373-376.